Inventors (old) • Bioventures

Inventors

Bioventures' Pathway to Patents

The invention disclosure process can be overwhelming at times, which is why we have broken down the step by step process for you. Here you can read the timeline in a simple and clear way. If you are an inventor, click here to read a more detailed description of the process.

Step 1

Invention Disclosure

Submit the invention disclosure form stating the current status of your invention.

Step 2

Technology Assessment Report

Our team will complete the TAR, a structured summative document regarding your invention. This includes a snapshot of colesely related inventions, and preliminary market analysis.

Step 3

Technology Assessment Deck

The slide deck helps us focus the technology assessment report even more and allows us to send the information to individuals in the industry to help us assess the technology.

Step 4

Patent and Copyright Committee Presentation

The Bioventures team preset the technology to the Committee with the collaboration of the inventor.

Step 6

Determination

After the Patent and Copyright Committee meet, there are 3 possible determinations.

Start now!

To start the process, the first step is to fill out the Invention Disclosure Questionnaire. Log in to Wellspring Sophia and click “Login through UAMS”.

Latest News and Updates

Events

BioVentures participates in AUTM University Conference 2025 in New Orleans

BioVentures participated in the AUTM University Conference 2025, held from October 26–29 in New Orleans. The event brought together professionals from technology transfer offices across the country to exchange knowledge, explore emerging trends, and strengthen collaboration within the tech transfer community. The conference offered a valuable opportunity to learn from experts, exchange best practices, and strengthen collaboration across the national tech transfer network. “From insightful sessions to meaningful networking moments, this experience was truly inspiring,” said Britney Bobo, Project Coordinator at BioVentures. “I had the chance to learn from industry experts, share ideas with peers, and dive deeper into the evolving world of tech transfer and innovation.” By taking part in AUTM University, BioVentures reinforces its commitment to advancing technology commercialization and promoting innovation through collaboration and professional development.

November 12, 2025

Events

BioVentures participates in Bio on the Bayou 2025 in New Orleans

BioVentures attended Bio on the Bayou 2025 in New Orleans, a leading regional event that brought together innovators, researchers, and investors to showcase the latest advances in biotechnology, medtech, and health sciences. The conference gathered academic and industry leaders to highlight cutting-edge research and explore new opportunities for collaboration and commercialization. For BioVentures, it was an opportunity to connect with peers across the region and demonstrate the growing strength of Arkansas’s biotech ecosystem. As Eric Peterson, President of BioVentures, noted, Bio on the Bayou served as a platform to reinforce the organization’s active role in expanding technology commercialization and innovation networks throughout the South.

November 12, 2025

Blog

BioVentures Receives Chancellor’s Circle Grant to Expand Student Innovation Training

BioVentures LLC has been awarded a $15,000 Chancellor’s Circle Grant to support the initiative “Empowering Student Innovation: Building an Innovation and Entrepreneurship Ecosystem at UAMS.” The program provides UAMS medical and STEM students with hands-on training in intellectual property, startup development, translational research, and commercialization. By integrating scientific research, technology transfer, and entrepreneurial education, it creates structured, experiential pathways for students and trainees to transform scientific ideas into innovations that improve the health and well-being of Arkansans. Megan Reed, Ph.D., MBA, senior licensing associate with BioVentures, accepted the grant on behalf of the organization. This initiative reflects BioVentures’ ongoing mission to bridge research and commercialization at UAMS and to empower the next generation of innovators working to translate discoveries into real-world health solutions.

November 12, 2025

Subscribe to our Newsletter

Stay tuned with BioVentures’ newsletter for inventors: news, events, resources and more!